InflaRx N.V. (IFRX) — Analyst outlook / Analyst consensus target is. Based on 15 analyst ratings, the consensus is bullish — 1 Strong Buy, 11 Buy, 2 Hold, 1 Sell.
The consensus price target is $2.00, representing an upside of 65.3% from the current price $1.21.
Analysts estimate Earnings Per Share (EPS) of $-0.93 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.78 vs est $-0.93 (beat +15.7%). 2025: actual $-0.66 vs est $-0.68 (beat +2.9%). Analyst accuracy: 89%.
IFRX Stock — 12-Month Price Forecast
$2.00
▲ +65.29% Upside
Average Price Target
Based on 15 Wall Street analysts offering 12-month price targets for InflaRx N.V., the price target is $2.00.
The average price target represents a +65.29% change from the last price of $1.21.
IFRX Analyst Ratings
Buy
Based on 15 analysts giving stock ratings to InflaRx N.V. in the past 3 months
EPS Estimates — IFRX
89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.78
vs Est –$0.93
▲ 18.7% off
2025
Actual –$0.66
vs Est –$0.68
▲ 3.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — IFRX
7%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 31.5% off
2025
Actual $0.000B
vs Est $0.000B
▼ 153.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
